Wells Fargo
UNCY icon

Wells Fargo’s Unicycive Therapeutics UNCY Stock Holding History

Wells Fargo’s Portfolio UNCY Stock Details UNCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$104K Buy
+22,069
New +$163K ﹤0.01% 5521
2024
Q2 		– Sell
-20
Closed -$270 – 7478
2024
Q1 		$270 Buy
20
+1
+5% +$12 ﹤0.01% 6429
2023
Q4 		$167 Buy
19
+15
+375% +$98 ﹤0.01% 6651
2023
Q3 		$34 Sell
4
-1
-20% -$9 ﹤0.01% 7030
2023
Q2 		$63 Hold
5
– – ﹤0.01% 6991
2023
Q1 		$99 Hold
5
– – ﹤0.01% 6941
2022
Q4 		$25 Hold
5
– – ﹤0.01% 7231
2022
Q3 		$0 Buy
5
+1
+25% +$7 ﹤0.01% 7407
2022
Q2 		$0 Buy
4
+1
+33% +$10 ﹤0.01% 7529
2022
Q1 		$0 Hold
3
– – ﹤0.01% 7849
2021
Q4 		$0 Hold
3
– – ﹤0.01% 7837
2021
Q3 		$0 Buy
+3
New +$86 ﹤0.01% 7547

Other funds holding UNCY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return

Wells Fargo's UNCY Position: Q2 2026 in Review

Wells Fargo opened a new position in Unicycive Therapeutics (UNCY) in Q2 2026: 22,069 shares worth $104K. The stake represents ﹤0.01% of the portfolio and ranks #5521 among its holdings. This is a return to the name: Wells Fargo previously reported a position in UNCY as recently as Q1 2024.

Wells Fargo first reported a position in UNCY in Q3 2021 and has held it in 12 quarters since. 80 funds tracked by Wall St. Rank hold UNCY as of Q2 2026.

  • Wells Fargo held 22,069 shares of Unicycive Therapeutics worth $104K as of Q2 2026.
  • Unicycive Therapeutics was a new Wells Fargo position in Q2 2026.
  • Unicycive Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #5521 holding.
  • Wells Fargo first reported a position in Unicycive Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • 80 funds tracked by Wall St. Rank held Unicycive Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.